Evidence map›Paper›PMID 40609560›Full record

ArticleLancet (London, England)2025

Evaluating the impact of two decades of USAID interventions and projecting the effects of defunding on mortality up to 2030: a retrospective impact evaluation and forecasting analysis.

Daniella Medeiros Cavalcanti, Lucas de Oliveira Ferreira de Sales, Andrea Ferreira da Silva, Elisa Landin Basterra, Daiana Pena, Caterina Monti, Gonzalo Barreix, Natanael J Silva, Paula Vaz, Francisco Saute and 5 more

Abstract read
In one paragraph

Article in Lancet (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Ways to address health financing pressures and donor transition, Kenya.Bulletin of the World Health Organization · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Daniella Medeiros CavalcantiInstitute of Collective Health, Federal University of Bahia, Bahia, Brazil.
Lucas de Oliveira Ferreira de SalesInstitute of Collective Health, Federal University of Bahia, Bahia, Brazil.
Andrea Ferreira da SilvaInstitute of Collective Health, Federal University of Bahia, Bahia, Brazil.
Elisa Landin BasterraISGlobal, Barcelona, Spain; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.
Daiana PenaISGlobal, Barcelona, Spain; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.
Caterina MontiISGlobal, Barcelona, Spain; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.
Gonzalo BarreixISGlobal, Barcelona, Spain; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.
Natanael J SilvaISGlobal, Barcelona, Spain; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.
Paula VazFundação Ariel Glaser, Maputo, Mozambique.
Francisco SauteCentro de Investigação em Saúde de Manhiça, Maputo, Mozambique.
Gonzalo FanjulISGlobal, Barcelona, Spain.
Quique BassatISGlobal, Barcelona, Spain; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain; Paediatrics Department, Hospital Sant Joan de Déu, Universitat de Barcelona, Barcelona, Spain; Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique; ICREA, Barcelona, Spain; Institut Clínic de Medicina I Dermatologia, Hospital Clínic de Barcelona, Barcelona, Spain; CIBER de Epidemiología y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain.
Denise NanicheISGlobal, Barcelona, Spain; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain.
James MacinkoUniversity of California, Los Angeles, CA, USA.
Davide RasellaInstitute of Collective Health, Federal University of Bahia, Bahia, Brazil; ISGlobal, Barcelona, Spain; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona, Barcelona, Spain; ICREA, Barcelona, Spain. Electronic address: davide.rasella@isglobal.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe US Agency for International Development (USAID) is the largest funding agency for humanitarian and development aid worldwide. The aim of this study is to comprehensively evaluate the effect of all USAID funding on adult and child mortality over the past two decades and forecast the future effect of its defunding.

methodsIn this retrospective impact evaluation integrated with forecasting analysis, we used panel data from 133 countries and territories- including all low-income and middle-income countries (LMICs)-with USAID support ranging from none to very high. First, we used fixed-effects multivariable Poisson models with robust SEs adjusted for demographic, socioeconomic, and health-care factors to estimate the impact of USAID funding on all-age and all-cause mortality from 2001 to 2021. Second, we evaluated its effects by age-specific, sex-specific, and cause-specific groups. Third, we did several sensitivity and triangulation analyses. Lastly, we integrated the retrospective evaluation with validated dynamic microsimulation models to estimate effects up to 2030.

findingsHigher levels of USAID funding-primarily directed toward LMICs, particularly African countries-were associated with a 15% reduction in age-standardised all-cause mortality (risk ratio [RR] 0·85, 95% CI 0·78-0·93) and a 32% reduction in under-five mortality (RR 0·68, 0·57-0·80). This finding indicates that 91 839 663 (95% CI 85 690 135-98 291 626) all-age deaths, including 30 391 980 (26 023 132-35 482 636) in children younger than 5 years, were prevented by USAID funding over the 21-year study period. USAID funding was associated with a 65% reduction (RR 0·35, 0·29-0·42) in mortality from HIV/AIDS (representing 25·5 million deaths), 51% (RR 0·49, 0·39-0·61) from malaria (8·0 million deaths), and 50% (RR 0·50, 0·40-0·62) from neglected tropical diseases (8·9 million deaths). Significant decreases were also observed in mortality from tuberculosis, nutritional deficiencies, diarrhoeal diseases, lower respiratory infections, and maternal and perinatal conditions. Forecasting models predicted that the current steep funding cuts could result in more than 14 051 750 (uncertainty interval 8 475 990-19 662 191) additional all-age deaths, including 4 537 157 (3 124 796-5 910 791) in children younger than age 5 years, by 2030.

interpretationUSAID funding has significantly contributed to the reduction in adult and child mortality across low-income and middle-income countries over the past two decades. Our estimates show that, unless the abrupt funding cuts announced and implemented in the first half of 2025 are reversed, a staggering number of avoidable deaths could occur by 2030.

fundingThe Spanish Ministry of Science and Innovation, UK Medical Research Council, and EU Horizon Europe.

Indexed as

Child MortalityMortalityAdolescentAdultChildChild, PreschoolDeveloping CountriesFemaleForecastingHumansInfantInfant, NewbornInternational CooperationMaleMiddle AgedRetrospective Studies

Identifiers

PMID40609560
PMCPMC12274115

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.